These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24293347)

  • 1. Genetics and personalized medicine--a role in statin therapy?
    Patel J; Abd T; Blumenthal RS; Nasir K; Superko HR
    Curr Atheroscler Rep; 2014 Jan; 16(1):384. PubMed ID: 24293347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of pharmacogenetic variation on the effects of statins.
    Maggo SD; Kennedy MA; Clark DW
    Drug Saf; 2011 Jan; 34(1):1-19. PubMed ID: 21142270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.
    Hoffmann MM
    Curr Cardiol Rep; 2018 May; 20(7):56. PubMed ID: 29802474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.
    Postmus I; Verschuren JJ; de Craen AJ; Slagboom PE; Westendorp RG; Jukema JW; Trompet S
    Pharmacogenomics; 2012 May; 13(7):831-40. PubMed ID: 22594514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.
    Ahangari N; Doosti M; Ghayour Mobarhan M; Sahebkar A; Ferns GA; Pasdar A
    Ann Med; 2020 Dec; 52(8):462-470. PubMed ID: 32735150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of statin response.
    Mangravite LM; Wilke RA; Zhang J; Krauss RM
    Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia.
    Maxwell WD; Ramsey LB; Johnson SG; Moore KG; Shtutman M; Schoonover JH; Kawaguchi-Suzuki M
    Pharmacotherapy; 2017 Sep; 37(9):1172-1190. PubMed ID: 28672099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid intima media-thickness and genes involved in lipid metabolism in diabetic patients using statins--a pathway toward personalized medicine.
    Starčević JN; Petrovič D
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):3-8. PubMed ID: 22845899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of statins therapy.
    Puccetti L; Acampa M; Auteri A
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):228-36. PubMed ID: 18221122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowing pharmacogenomics in Chinese patients.
    Hu M; Tomlinson B
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):985-97. PubMed ID: 23952137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of response to statins.
    Zineh I
    Curr Atheroscler Rep; 2007 Sep; 9(3):187-94. PubMed ID: 18241612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.
    Schmitz G; Drobnik W
    Clin Chem Lab Med; 2003 Apr; 41(4):581-9. PubMed ID: 12747606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.
    Ruaño G; Seip R; Windemuth A; Wu AH; Thompson PD
    Clin Lab Med; 2016 Sep; 36(3):473-91. PubMed ID: 27514463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin response and pharmacokinetics variants.
    Kajinami K; Masuya H; Hoshiba Y; Takeda K; Sato R; Okabayashi M; Schaefer EJ
    Expert Opin Pharmacother; 2005 Jul; 6(8):1291-7. PubMed ID: 16013979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of response to statins: where do we stand?
    Maitland-van der Zee AH; Boerwinkle E
    Curr Atheroscler Rep; 2005 May; 7(3):204-8. PubMed ID: 15811254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease.
    Streja E; Streja DA; Soohoo M; Kleine CE; Hsiung JT; Park C; Moradi H
    Semin Nephrol; 2018 Jul; 38(4):369-382. PubMed ID: 30082057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins personalized.
    Superko HR; Momary KM; Li Y
    Med Clin North Am; 2012 Jan; 96(1):123-39. PubMed ID: 22391257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.